On Dec. 1, Pfizer (PFE 0.52%) reported some less-than-great news to investors. In short, its…
U.K.-based AstraZeneca (AZN 0.52%) is now gearing up for the second time to develop a…
Get ahead of the game. Sign up today and gain a competitive edge in the world of trading
Don’t miss out on this opportunity to boost your trading potential and maximize your profits. Start trading with us and watch your investments grow!